tiprankstipranks
Trending News
More News >
RUA Life Sciences (GB:RUA)
LSE:RUA
UK Market

RUA Life Sciences (RUA) Ratios

Compare
3 Followers

RUA Life Sciences Ratios

GB:RUA's free cash flow for Q4 2024 was £0.74. For the 2024 fiscal year, GB:RUA's free cash flow was decreased by £ and operating cash flow was £-0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.91 9.01 5.20 8.23 6.67
Quick Ratio
4.23 8.81 5.00 7.99 6.59
Cash Ratio
3.24 7.10 3.58 5.80 5.73
Solvency Ratio
0.23 -1.09 -1.90 -2.02 -0.71
Operating Cash Flow Ratio
-0.20 -2.40 -2.84 -4.62 -1.29
Short-Term Operating Cash Flow Coverage
-0.92 -42.84 -40.48 -102.65 -61.87
Net Current Asset Value
£ 3.55M£ 4.01M£ 1.29M£ 3.34M£ 5.68M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.05 0.08 0.05 0.04
Debt-to-Equity Ratio
0.14 0.05 0.10 0.05 0.05
Debt-to-Capital Ratio
0.12 0.05 0.09 0.05 0.05
Long-Term Debt-to-Capital Ratio
<0.01 0.02 0.03 0.03 0.03
Financial Leverage Ratio
1.27 1.14 1.21 1.16 1.19
Debt Service Coverage Ratio
1.49 -8.71 -36.20 -56.32 -17.21
Interest Coverage Ratio
-29.09 -23.34 -149.38 -303.63 -41.77
Debt to Market Cap
0.03 0.06 0.02 0.02 <0.01
Interest Debt Per Share
0.02 0.01 0.02 0.02 0.03
Net Debt to EBITDA
-6.33 2.25 0.52 1.28 4.60
Profitability Margins
Gross Profit Margin
72.79%78.32%65.76%64.31%64.14%
EBIT Margin
-0.49%-88.41%-106.06%-144.55%-102.03%
EBITDA Margin
9.75%-71.79%-89.40%-125.48%-83.70%
Operating Profit Margin
-24.05%-88.41%-109.68%-149.48%-117.54%
Pretax Profit Margin
-0.24%-92.20%-106.56%-145.23%-104.32%
Net Profit Margin
0.02%-65.72%-91.92%-127.20%-94.96%
Continuous Operations Profit Margin
-0.27%-65.72%-91.92%-127.20%-94.96%
Net Income Per EBT
-10.00%71.29%86.26%87.58%91.03%
EBT Per EBIT
1.01%104.28%97.15%97.16%88.75%
Return on Assets (ROA)
0.01%-17.63%-35.37%-27.10%-14.29%
Return on Equity (ROE)
0.01%-20.05%-42.77%-31.39%-17.06%
Return on Capital Employed (ROCE)
-12.13%-25.44%-45.53%-34.14%-19.83%
Return on Invested Capital (ROIC)
-12.73%-17.86%-38.47%-29.64%-17.93%
Return on Tangible Assets
0.01%-19.33%-43.63%-31.79%-15.64%
Earnings Yield
0.01%-49.03%-17.53%-19.01%-5.79%
Efficiency Ratios
Receivables Turnover
3.77 4.12 3.71 1.45 3.17
Payables Turnover
1.64 3.39 17.35 3.14 2.09
Inventory Turnover
1.48 4.24 9.21 4.68 6.45
Fixed Asset Turnover
1.30 0.89 0.80 0.63 0.78
Asset Turnover
0.44 0.27 0.38 0.21 0.15
Working Capital Turnover Ratio
0.88 0.71 0.80 0.33 0.37
Cash Conversion Cycle
120.07 67.11 117.09 213.18 -2.89
Days of Sales Outstanding
96.91 88.63 98.49 251.57 115.00
Days of Inventory Outstanding
245.94 86.06 39.63 78.03 56.61
Days of Payables Outstanding
222.78 107.58 21.04 116.42 174.51
Operating Cycle
342.85 174.69 138.13 329.60 171.62
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -0.04 -0.05 -0.11 -0.08
Free Cash Flow Per Share
>-0.01 -0.04 -0.07 -0.15 -0.12
CapEx Per Share
<0.01 <0.01 0.02 0.04 0.04
Free Cash Flow to Operating Cash Flow
1.29 1.04 1.38 1.38 1.44
Dividend Paid and CapEx Coverage Ratio
-3.47 -24.15 -2.61 -2.61 -2.30
Capital Expenditure Coverage Ratio
-3.47 -24.15 -2.61 -2.61 -2.30
Operating Cash Flow Coverage Ratio
-0.21 -3.41 -2.47 -6.86 -3.47
Operating Cash Flow to Sales Ratio
-0.05 -0.61 -0.54 -1.45 -0.93
Free Cash Flow Yield
-3.43%-47.09%-14.21%-30.04%-8.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
8.07K -2.04 -5.70 -5.26 -17.26
Price-to-Sales (P/S) Ratio
1.96 1.34 5.24 6.69 16.39
Price-to-Book (P/B) Ratio
1.11 0.41 2.44 1.65 2.94
Price-to-Free Cash Flow (P/FCF) Ratio
-29.13 -2.12 -7.04 -3.33 -12.26
Price-to-Operating Cash Flow Ratio
-37.53 -2.21 -9.73 -4.60 -17.60
Price-to-Earnings Growth (PEG) Ratio
189.30 0.04 1.83 -0.39 -0.36
Price-to-Fair Value
1.11 0.41 2.44 1.65 2.94
Enterprise Value Multiple
13.79 0.38 -5.35 -4.05 -14.98
Enterprise Value
5.53M -604.94K 10.42M 8.25M 19.16M
EV to EBITDA
13.79 0.38 -5.35 -4.05 -14.98
EV to Sales
1.34 -0.28 4.78 5.08 12.54
EV to Free Cash Flow
-19.96 0.44 -6.42 -2.53 -9.38
EV to Operating Cash Flow
-25.72 0.46 -8.87 -3.49 -13.46
Tangible Book Value Per Share
0.11 0.19 0.17 0.25 0.41
Shareholders’ Equity Per Share
0.12 0.21 0.21 0.30 0.48
Tax and Other Ratios
Effective Tax Rate
-0.10 0.29 0.14 0.12 0.09
Revenue Per Share
0.07 0.07 0.10 0.07 0.09
Net Income Per Share
<0.01 -0.04 -0.09 -0.09 -0.08
Tax Burden
-0.10 0.71 0.86 0.88 0.91
Interest Burden
0.50 1.04 1.00 1.00 1.02
Research & Development to Revenue
0.00 0.40 0.50 0.57 0.38
SG&A to Revenue
1.01 0.52 0.30 0.49 1.84
Stock-Based Compensation to Revenue
0.01 -0.02 0.05 0.09 0.08
Income Quality
-215.00 0.92 0.59 1.14 0.98
Currency in GBP